WO2007054976A3 - Lipid based controlled release pharmaceutical composition - Google Patents
Lipid based controlled release pharmaceutical composition Download PDFInfo
- Publication number
- WO2007054976A3 WO2007054976A3 PCT/IN2006/000438 IN2006000438W WO2007054976A3 WO 2007054976 A3 WO2007054976 A3 WO 2007054976A3 IN 2006000438 W IN2006000438 W IN 2006000438W WO 2007054976 A3 WO2007054976 A3 WO 2007054976A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- controlled release
- release pharmaceutical
- pharmaceutical composition
- lipid based
- based controlled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Novel controlled release pharmaceutical compositions are provided which release the active agent(s) over an extended period of time comprising a core wherein the said core comprises at least one active agent(s) which is preferably water soluble, a lipid system comprising at least one lipid component(s), at least one water insoluble release modifier(s), at least one channel forming agent(s) and optionally one or more pharmaceutically acceptable excipients; and at least one coat. Preferably the coating composition comprises at least one hydrophilic pH independent polymer(s) and optionally one or more pharmaceutically acceptable excipients. Also provided is a process of preparation of such compositions and method of using them.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2985DEL/2005 | 2005-11-08 | ||
IN2985DE2005 | 2005-11-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007054976A2 WO2007054976A2 (en) | 2007-05-18 |
WO2007054976A3 true WO2007054976A3 (en) | 2007-08-09 |
Family
ID=38023688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2006/000438 WO2007054976A2 (en) | 2005-11-08 | 2006-11-07 | Lipid based controlled release pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007054976A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8377977B2 (en) | 2004-08-13 | 2013-02-19 | Boehringer Ingelheim International Gmbh | Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
US8637540B2 (en) | 2003-11-26 | 2014-01-28 | Acura Pharmaceuticals | Compositions for deterring abuse of opioid containing dosage forms |
US8715728B2 (en) | 2004-08-13 | 2014-05-06 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
US8901113B2 (en) | 2009-09-30 | 2014-12-02 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
US9101636B2 (en) | 2012-11-30 | 2015-08-11 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050226926A1 (en) | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
WO2007090882A2 (en) * | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical extended release compositions comprising pramipexole |
WO2008114280A1 (en) * | 2007-03-21 | 2008-09-25 | Lupin Limited | Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
JP2010525018A (en) * | 2007-04-24 | 2010-07-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Composition with sustained-release tablet-type preparation containing pramipexole or a pharmaceutically acceptable salt thereof |
WO2010083360A2 (en) * | 2009-01-16 | 2010-07-22 | Mutual Pharmaceutical Company, Inc. | Controlled-release formulations |
EP2564836A1 (en) * | 2009-05-20 | 2013-03-06 | Ranbaxy Laboratories Limited | Controlled release lamotrigine formulations |
TR200905670A1 (en) * | 2009-07-22 | 2011-02-21 | Sanovel �La� San.Ve T�C.A.�. | Levetiracetam pharmaceutical compositions for prolonged release |
TR201001862A1 (en) * | 2010-03-11 | 2011-10-21 | Sanovel �La� San.Ve T�C.A.�. | Controlled release pramipexole formulations. |
EP2380560A1 (en) * | 2010-04-22 | 2011-10-26 | ratiopharm GmbH | Matrix tablets containing pramipexol |
KR101307334B1 (en) * | 2010-07-02 | 2013-09-12 | 주식회사 바이오파마티스 | Sustained-release pharmaceutical composition comprising pramipexole or pharmaceutically acceptable salt thereof having improved stability |
WO2013058409A1 (en) | 2011-10-21 | 2013-04-25 | Takeda Pharmaceutical Company Limited | Sustained-release preparation |
CN104367562A (en) * | 2013-08-15 | 2015-02-25 | 上海星泰医药科技有限公司 | Pramipexole dihydrochloride slow-release tablets and preparation method thereof |
EP3242565A4 (en) * | 2015-01-07 | 2018-06-27 | Corr-Jensen Inc. | Compositions and methods for enhancing athletic performance |
US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
KR20190028656A (en) * | 2016-05-11 | 2019-03-19 | 렐마다 테라퓨틱스, 인크. | Abrasion resistant opioid formulation |
CN106727357B (en) * | 2017-01-19 | 2020-09-18 | 杭州益品新五丰药业有限公司 | Acyclovir granules and preparation method thereof |
CN109125270B (en) * | 2017-06-27 | 2021-03-19 | 广州帝奇医药技术有限公司 | Solid preparation and preparation method thereof |
WO2021033182A1 (en) * | 2019-08-16 | 2021-02-25 | Adel Penhasi | Adhesive drug delivery film and a microparticle comprising thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003063834A1 (en) * | 2002-02-01 | 2003-08-07 | Pacific Corporation | Multi-stage oral drug controlled-release system |
WO2004012699A2 (en) * | 2002-08-05 | 2004-02-12 | Torrent Pharmaceuticals Limited | Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent |
US20040062800A1 (en) * | 2000-12-20 | 2004-04-01 | Burnside Beth A. | Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
-
2006
- 2006-11-07 WO PCT/IN2006/000438 patent/WO2007054976A2/en active Search and Examination
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040062800A1 (en) * | 2000-12-20 | 2004-04-01 | Burnside Beth A. | Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
WO2003063834A1 (en) * | 2002-02-01 | 2003-08-07 | Pacific Corporation | Multi-stage oral drug controlled-release system |
WO2004012699A2 (en) * | 2002-08-05 | 2004-02-12 | Torrent Pharmaceuticals Limited | Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8637540B2 (en) | 2003-11-26 | 2014-01-28 | Acura Pharmaceuticals | Compositions for deterring abuse of opioid containing dosage forms |
US8822489B2 (en) | 2003-11-26 | 2014-09-02 | Acura Pharmaceuticals | Abuse deterrent compositions and methods of making same |
US9492443B2 (en) | 2003-11-26 | 2016-11-15 | Acura Pharmaceuticals, Inc. | Abuse deterrent compositions and methods of making same |
US8377977B2 (en) | 2004-08-13 | 2013-02-19 | Boehringer Ingelheim International Gmbh | Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
US8715728B2 (en) | 2004-08-13 | 2014-05-06 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
US8901113B2 (en) | 2009-09-30 | 2014-12-02 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
US9101636B2 (en) | 2012-11-30 | 2015-08-11 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US9320796B2 (en) | 2012-11-30 | 2016-04-26 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
Also Published As
Publication number | Publication date |
---|---|
WO2007054976A2 (en) | 2007-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007054976A3 (en) | Lipid based controlled release pharmaceutical composition | |
WO2008022932A3 (en) | Controlled release system and method for manufacturing the same | |
WO2007000778A3 (en) | Modified release pharmaceutical compositions on the basis of two polymers and processes thereof | |
TNSN08365A1 (en) | Sustained release pharmaceutical composition on the basis of release system comprising an acid-soluble polymer and a ph-dependent polymer | |
WO2006039499A3 (en) | Method for improving the biovailability of orally delivered therapeutics | |
WO2004062577A3 (en) | Two or more enteric materials to regulate drug release | |
WO2007020259A3 (en) | Controlled release pharmaceutical compositions for acid labile drugs | |
WO2008061226A3 (en) | Sustained-release formulations of topiramate | |
WO2006121941A3 (en) | Pharmaceutical compositions comprising imatinib and a release retardant | |
WO2005123134A3 (en) | A controlled release delivery system for metformin | |
WO2001052816A3 (en) | Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same | |
BR9915087A (en) | Enteric coated oral pharmaceutical formulation, use of a hydroxypropyl cellulose (hpc) quality, process for the manufacture of an enteric coated oral pharmaceutical formulation, use of a pharmaceutical formulation, and method for the treatment of gastrointestinal diseases in mammals, including man | |
WO2007086078A3 (en) | Novel pharmaceutical compositions and process of preparation thereof | |
WO2007034503A3 (en) | Controlled release dosage formulation of duloxetine | |
EP2110135A3 (en) | A pharmaceutical composition for treating depression and method for preparation thereof | |
WO2006058250A3 (en) | Orally disintegrating compositions | |
WO2010037854A3 (en) | Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules | |
WO2001070197A3 (en) | Method for preparing high pressure/high shear dispersions containing physiologically active ingredients | |
WO2008084698A1 (en) | Tacrolimus sustained release pharmaceutical composition | |
MY130332A (en) | Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer | |
WO2006123364A3 (en) | Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative | |
WO2003057150A3 (en) | A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof | |
WO2005007074A3 (en) | Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention | |
WO2004066984A3 (en) | Improved taste masking pharmaceutical composition and process for its preparation | |
MX339136B (en) | Pulsed-release sildenafil composition and method for preparing said composition. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06821697 Country of ref document: EP Kind code of ref document: A2 |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |